Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Martin

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
The Biochemical Journal|March 26, 2021
Syntaxins 6 and 8 facilitate tau into secretory pathwaysWei Siang Lee, Daniel Cs Tan, Yuanyuan Deng, et al.
Health Technology Assessment (Winchester, England)|March 23, 2021
Sacral nerve stimulation versus the magnetic sphincter augmentation device for adult faecal incontinence: the SaFaRI RCTDavid G Jayne, Annabelle E Williams, Neil Corrigan, et al.
Plos One|April 15, 2022
Collection of cancer Patient Reported Outcome Measures (PROMS) to link with primary and secondary electronic care records to understand and improve long term cancer outcomes: A protocol paperElizabeth Stamp, Gemma Clarke, Penny Wright, et al.
Health and Social Care Delivery Research|August 2, 2025
Evaluation of the NHS England Low-Calorie Diet implementation pilot: a coproduced mixed-method studyLouisa J Ells, Tamara Brown, Jamie Matu, et al.
BMJ Open|February 2, 2026
Adult survivors of sickle cell disease, transfusion-dependent beta-thalassaemia and childhood acute leukaemia in England: protocol for a mixed methods data linkage and health-related quality of life survey studyKhalid Ahmed, Ivana Holloway, Kate Absolom, et al.
Aging & Mental Health|April 14, 2020
Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trialClaire A Surr, Ivana Holloway, Rebecca E A Walwyn, et al.
The Lancet. Oncology|February 16, 2023
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trialJanet E Brown, Kara-Louise Royle, Walter Gregory, et al.
Health Technology Assessment (Winchester, England)|March 29, 2020
Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCTClaire A Surr, Ivana Holloway, Rebecca Ea Walwyn, et al.
Health Technology Assessment (Winchester, England)|September 9, 2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCTFiona Collinson, Kara-Louise Royle, Jayne Swain, et al.
Kidney International|May 8, 2021
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular diseaseSimon A Carter, Charlotte Logeman, Martin Howell, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
The Biochemical Journal|March 26, 2021
Syntaxins 6 and 8 facilitate tau into secretory pathwaysWei Siang Lee, Daniel Cs Tan, Yuanyuan Deng, et al.
Health Technology Assessment (Winchester, England)|March 23, 2021
Sacral nerve stimulation versus the magnetic sphincter augmentation device for adult faecal incontinence: the SaFaRI RCTDavid G Jayne, Annabelle E Williams, Neil Corrigan, et al.
Plos One|April 15, 2022
Collection of cancer Patient Reported Outcome Measures (PROMS) to link with primary and secondary electronic care records to understand and improve long term cancer outcomes: A protocol paperElizabeth Stamp, Gemma Clarke, Penny Wright, et al.
Health and Social Care Delivery Research|August 2, 2025
Evaluation of the NHS England Low-Calorie Diet implementation pilot: a coproduced mixed-method studyLouisa J Ells, Tamara Brown, Jamie Matu, et al.
BMJ Open|February 2, 2026
Adult survivors of sickle cell disease, transfusion-dependent beta-thalassaemia and childhood acute leukaemia in England: protocol for a mixed methods data linkage and health-related quality of life survey studyKhalid Ahmed, Ivana Holloway, Kate Absolom, et al.
Aging & Mental Health|April 14, 2020
Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trialClaire A Surr, Ivana Holloway, Rebecca E A Walwyn, et al.
The Lancet. Oncology|February 16, 2023
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trialJanet E Brown, Kara-Louise Royle, Walter Gregory, et al.
Health Technology Assessment (Winchester, England)|March 29, 2020
Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCTClaire A Surr, Ivana Holloway, Rebecca Ea Walwyn, et al.
Health Technology Assessment (Winchester, England)|September 9, 2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCTFiona Collinson, Kara-Louise Royle, Jayne Swain, et al.
Kidney International|May 8, 2021
Development of an international Delphi survey to establish core outcome domains for trials in adults with glomerular diseaseSimon A Carter, Charlotte Logeman, Martin Howell, et al.
Pageof 10